No Data
No Data
MBX Biosciences' Investigational Drug For Weight Loss Surgery-Related Low Blood Sugar Shows Encouraging Action
MBX Biosciences' MBX 1416 Shows Positive Phase 1 Data In PBH; Stock Down In Pre-market
Express News | Mbx Biosciences Inc - 1416 Generally Well-Tolerated With Favorable Safety Profile
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Earnings Scheduled For December 19, 2024
MBX Biosciences to Participate in 43rd Annual J.P. Morgan Healthcare Conference
No Data